ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1449

Microwave Radiometry As a Novel Additional Method for Rheumatoid Arthritis Disease Activity Assessment: A Prospective Single-Center Study

Katerina Laskari1, George Pentazos1, George Konstantonis1, Maria Tektonidou1, Elias Siores2 and Petros Sfikakis1, 1Rheumatology Unit, 1st Dept. of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Athens University Medical School, Athens, Greece, 2Institute of Materials Research and Innovation, University of Bolton, Bolton, United Kingdom

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: imaging techniques and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Microwave Radiometry (MR) is an easy-to perform, rapid, non-invasive method detecting in-depth tissue temperature that may be useful for joint inflammation assessment in RA (1,2). We tested the hypothesis that MR can diagnose and grade (teno)synovitis in small and large joints in RA; thus, may be used for the development of an MR-derived combined joint-temperature score to measure RA disease activity.

Methods:

Eighty-two RA patients and 23 age- and sex-matched healthy individuals, underwent MR, clinical and laboratory assessments and joint ultrasound, as described (2); 21 patients were re-examined 2 months after treatment initiation. The temperature of each joint was expressed by Δt (difference between MR-derived temperature of pre-defined joint points resulting in lower Δt values in warmer joints). A thermo-score was created by summing the Δt of 7 small joints according to the US7 ultrasound score (wrist, 2nd-3rd MCP, 2nd-3rd PIP, 2nd and 5th MTP), as well as of elbow, knee and lower leg of the clinically dominant upper/lower extremity. This thermo-score was reproducible among healthy individuals (Intraclass Correlation Coefficient 0.714).

Results:

At the joint level, MR performed better than clinical examination in the knees to predict ultrasound confirmed joint effusion [area under the curve (AUC) 0.815 vs. 0.688, respectively), or power Doppler (AUC 0.901 vs. 0.791, respectively), whereas a Δt≤0.2 had 80% sensitivity and 82% specificity for power Doppler. Also, 85% of knee joints with subclinical inflammation could be diagnosed by MR. In all other joints MR performed similarly to clinical examination and its diagnostic performance was moderate. At individual patient level, the thermo-score strongly correlated to DAS28 score, tender and swollen joint counts, patient’s and physician’s visual analogue scale, CRP and ESR levels (all p<0.001), as well as to the US7 ultrasound scores (p<0.026). Moreover, the thermo-score could discriminate patients in high/moderate disease activity (mean±SD=4.6±3.0), low disease activity/remission (8.0±2.9) (p<0.001), or healthy subjects (8.8±1.9) (p<0.001). A thermo-score≤7.4 could distinguish highly/moderately active patients from healthy controls with a sensitivity and specificity of 81% and 83%, respectively (AUC 0.866), whereas a cut-off of 8.1 could distinguish highly/moderately active from patients in low activity/remission with both a sensitivity and specificity of 71% (AUC 0.802). Finally, individual changes from baseline to follow-up mirrored the corresponding DAS28 changes in 17/21 patients (p=0.001).

Conclusion:

Increased in-depth joint temperature detected by MR performed well for the detection of knee joint inflammation in RA. The MR-derived score of 10 selected joints correlated to clinical, laboratory and ultrasound measures of RA disease activity, could discriminate disease activity stages, as well as mirrored treatment-induced disease activity changes. Multicenter studies are needed to confirm these novel findings.

References

1. Zampeli E, et al. PLoS ONE 2013;8(5):e64606

2. Pentazos G, et al. J Clin Rheumatol 2018. E-pub ahead of print.


Disclosure: K. Laskari, None; G. Pentazos, None; G. Konstantonis, None; M. Tektonidou, None; E. Siores, None; P. Sfikakis, None.

To cite this abstract in AMA style:

Laskari K, Pentazos G, Konstantonis G, Tektonidou M, Siores E, Sfikakis P. Microwave Radiometry As a Novel Additional Method for Rheumatoid Arthritis Disease Activity Assessment: A Prospective Single-Center Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/microwave-radiometry-as-a-novel-additional-method-for-rheumatoid-arthritis-disease-activity-assessment-a-prospective-single-center-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microwave-radiometry-as-a-novel-additional-method-for-rheumatoid-arthritis-disease-activity-assessment-a-prospective-single-center-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology